Improving the management of acute coronary syndromes in Australia: translating evidence to outcomes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17535387)

Published in Intern Med J on June 01, 2007

Authors

L T Huynh1, P A Phillips, D P Chew

Author Affiliations

1: Department of Medicine, Cardiovascular Outcomes Research Group and Flinders Centre for Clinical Change and Healthcare Research, Flinders University, Adelaide, South Australia. luan.huynh@fmc.sa.gov.au

Articles by these authors

(truncated to the top 100)

Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13

Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation (2001) 1.83

Getting new evidence into medicine. Med J Aust (2000) 1.79

Vegetarian diet: panacea for modern lifestyle diseases? QJM (1999) 1.68

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation (2001) 1.62

Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. J Invasive Cardiol (2001) 1.59

Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J (2002) 1.50

Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes. Heart (2009) 1.47

Hospitals and hospitalists: an alternative view. Internal Medicine society of Australia and New Zealand. Med J Aust (1999) 1.42

Cardiac risk factor management. Experience of an outpatient hypertension clinic. Med J Aust (1991) 1.40

Influence of food on the bioavailability of a sustained-release verapamil preparation. J Pharm Sci (1990) 1.38

Chronic obstructive jaundice induced by Reovirus type 3 in weanling mice. Pathology (1969) 1.15

Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut (2005) 1.10

Aging and disturbances of thirst and fluid balance. Nutr Rev (1990) 1.06

Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway? Pancreas (2003) 1.01

Association of genital adenovirus infection with urethritis in men. Med J Aust (1984) 0.98

Adenovirus type 19 and a closely related new serotype in genital infection. Br J Vener Dis (1982) 0.95

Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med (1989) 0.95

Viral meningitis due to echovirus types 6 and 9: epidemiological data from Western Australia. Epidemiol Infect (1996) 0.93

Hydrocephalus in mice inoculated neonatally by the oronasal route with reovirus type 1. Science (1970) 0.91

Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol (1994) 0.91

Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: a PET study. Proc Natl Acad Sci U S A (2007) 0.90

Altered water excretion in healthy elderly men. Age Ageing (1987) 0.90

Osmotic thirst and vasopressin release in humans: a double-blind crossover study. Am J Physiol (1985) 0.89

Body fluid changes, thirst and drinking in man during free access to water. Physiol Behav (1984) 0.86

Cortical activation and lamina terminalis functional connectivity during thirst and drinking in humans. Am J Physiol Regul Integr Comp Physiol (2011) 0.85

Arteriovenous communication associated with obstructive arteriosclerotic coronary artery disease and myocardial infarction. Chest (1974) 0.84

Making decisions about delirium: a qualitative comparison of decision making between nurses working in palliative care, aged care, aged care psychiatry, and oncology. Palliat Med (2011) 0.84

Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates. J Hum Hypertens (1998) 0.83

Reversal of ketamine/xylazine anesthesia in the rabbit with yohimbine. Lab Anim Sci (1987) 0.83

Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat. Hypertension (1994) 0.83

Course of infection in tissues of susceptible chickens after exposure to strains of Marek's disease virus and turkey herpesvirus. J Natl Cancer Inst (1972) 0.82

Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone. Aust Vet J (2000) 0.81

Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism. Hypertension (1995) 0.81

Presence of functional vasopressin V1 receptors in rat vagal afferent neurones. Neurosci Lett (1992) 0.80

Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics. Arch Virol (1994) 0.80

The levodopa test in Parkinson's disease. Age Ageing (1995) 0.80

Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat. Clin Exp Pharmacol Physiol (1996) 0.80

Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A. Transplant Proc (1992) 0.80

Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus (2001) 0.79

Effects of aging on vasopressin secretion, water excretion, and thirst in man. Kidney Int Suppl (1987) 0.79

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk. J Thromb Thrombolysis (2001) 0.79

Unperceived treatment gaps in acute coronary syndromes. Int J Clin Pract (2009) 0.79

The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ (2005) 0.78

Human internal mammary artery responses to non-peptide vasopressin antagonists. Clin Exp Pharmacol Physiol (1994) 0.78

Impact of age, gender and indigenous status on access to diagnostic coronary angiography for patients presenting with non-ST segment elevation acute coronary syndromes in Australia. Intern Med J (2013) 0.78

Increased thirst and vasopressin secretion after myocardial infarction in rats. Am J Physiol Regul Integr Comp Physiol (2003) 0.78

Amylin stimulates plasma renin concentration in humans. Hypertension (1995) 0.78

Epidermal growth factor as a diuretic in sheep. J Physiol (1994) 0.78

[3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand. Peptides (1992) 0.78

Vascular responses to vasopressin antagonists in man and rat. Clin Sci (Lond) (1994) 0.78

Effects of aerial spray volume, coverage, and abamectin on Scirtothrips perseae (Thysanoptera: Thripidae). J Econ Entomol (2001) 0.77

Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension (1996) 0.77

Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor. Biochim Biophys Acta (1995) 0.77

Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension. Clin Exp Hypertens (1997) 0.77

[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors. J Recept Res (1989) 0.77

Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat. Clin Sci (Lond) (1998) 0.77

Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension (1992) 0.77

Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. Am J Physiol (1998) 0.77

Murine lymphoma induced by reovirus 3. Pathology (1971) 0.77

Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor. Am J Physiol (1993) 0.77

Vasopressin antisense peptide interactions with the V1 receptor. Peptides (1990) 0.76

Atrial natriuretic factor in normal man: effects of tilt, posture, exercise and haemorrhage. J Hypertens Suppl (1986) 0.76

Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR. Am J Physiol (1997) 0.76

Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat. Clin Exp Pharmacol Physiol (1994) 0.76

Influenza surveillance: alternative laboratory techniques for a developing country. Bull World Health Organ (1985) 0.75

Disseminating and applying best evidence. Med J Aust (1998) 0.75

A simple method for detecting mycoplasma infection of cell cultures. J Clin Pathol (1974) 0.75

Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260). Blood Press (1994) 0.75

Epidermal growth factor and fluid and electrolyte balance in the rat. Am J Physiol (1997) 0.75

Strengthening the scientific approach to clinical practice in the new physician training programme. Intern Med J (2008) 0.75

Twenty-four hour ambulatory blood pressure profiles following regular alcohol consumption. Am J Hypertens (1992) 0.75

Disruption of foraging by argentine ants,Iridomyrmex humilis (mayr) (hymenoptera: Formicidae), in citrus trees through the use of semiochemicals and related chemicals. J Chem Ecol (1992) 0.75

Isolation and characterization of the rat liver AVP receptor using [125I][d(CH2)5'sarcosine7]AVP. Clin Exp Pharmacol Physiol (1992) 0.75

A technique for saliva collection in dogs. Lab Anim Sci (1983) 0.75

Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats. Clin Exp Pharmacol Physiol (2003) 0.75

Characterization of monoclonal antibodies to a rat liver vasopressin receptor. Clin Exp Pharmacol Physiol (1991) 0.75

Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranes. Clin Exp Pharmacol Physiol (1993) 0.75

Effects of four days of regular, moderate consumption of ethanol on high-density lipoprotein cholesterol concentrations in plasma. Clin Chem (1990) 0.75

Cytomegalovirus isolation in highland children. P N G Med J (1983) 0.75

Isolation of Haemophilus ducreyi from a chancroid in Papua New Guinea. Med J Aust (1983) 0.75

Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborative. Intern Med J (2011) 0.75

The effects of short-term alcohol intake on clinic and ambulatory blood pressure in normotensive 'social' drinkers. Am J Hypertens (1995) 0.75

Effects of regular alcohol consumption on 24 hour ambulatory blood pressure recordings. Clin Exp Pharmacol Physiol (1990) 0.75

Surface chemistry and blood-material interactions (BMI). Trans Am Soc Artif Intern Organs (1983) 0.75

Pharmacokinetic comparison of a combination tablet of enalapril and hydrochlorothiazide with enalapril and hydrochlorothiazide tablets administered together and separately. Biopharm Drug Dispos (1991) 0.75

Murine disease induced by avian reovirus. Aust J Exp Biol Med Sci (1970) 0.75

Evaluation of the Coulter S-Plus IV three-part differential as a screening tool in a tertiary care hospital. Am J Clin Pathol (1987) 0.75

Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat. J Endocrinol (1993) 0.75

Effects of aerial spray volume, coverage, and sabadilla on Scirtothrips perseae (Thysanoptera: Thripidae). J Econ Entomol (2001) 0.75

Effects of an orally active vasopressin V1 receptor antagonist. Clin Exp Pharmacol Physiol (1993) 0.75

Renin-secreting adenocarcinoma of the colon. Ann Intern Med (1999) 0.75

Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibition. Adv Exp Med Biol (1998) 0.75

Effects of indomethacin on epidermal growth factor-induced renal responses in sheep. Clin Exp Pharmacol Physiol (1997) 0.75

An outbreak of influenza a in the highlands of Papua New Guinea. Southeast Asian J Trop Med Public Health (1984) 0.75

Interaction between epidermal growth factor and arginine vasopressin in renal medullary membranes. Clin Exp Pharmacol Physiol (1994) 0.75

Responses of vasoactive hormones in congestive cardiac failure. Can J Physiol Pharmacol (1987) 0.75

Health, economic, psychological and social impact of educating carers of patients with advanced pulmonary disease (protocol). Contemp Clin Trials (2011) 0.75